Login / Signup

A survey of knowledge, perceptions and use of core outcome sets among clinical trialists.

Chiara BellucciKaren HughesElaine ToomeyPaula R WilliamsonKaren Matvienko-Sikar
Published in: Trials (2021)
Enhancing clinical trialists' use of all COS outcomes is needed to reduce outcome heterogeneity and enhance comparability across trial findings. Enhancing awareness of COS importance among researchers and funders is needed to ensure that COS are developed and used by clinical trialists. Education and training may further promote awareness and understanding of COS.
Keyphrases
  • healthcare
  • clinical trial
  • study protocol
  • adipose tissue
  • single cell
  • metabolic syndrome
  • skeletal muscle
  • phase iii